Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk – a retrospective analysis of UNOS database

References

• Jacaud V. The immunogenicity of HLA class II mismatches: the predicted presentation of nonself Allo-HLA-derived peptide by the HLA-DR phenotype of the recipient is associated with the formation of DSA. J Immunol Res. 2017;2017:1.
   Web of Science ®Google Scholar
• Shi X, Lv J, Han W, et al. What is the impact of human leukocyte antigen mismatching on graft survival and mortality in renal transplantation? A meta-analysis of 23 cohort studies involving 486,608 recipients. BMC Nephrol. 2018;19(1):116.
   PubMedGoogle Scholar
• Cecka JM. Calculated PRA (CPRA): the new measure of sensitization for transplant candidates. Am J Transplant. 2010;10(1):26–9.
   PubMed Web of Science ®Google Scholar
• Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969;280(14):735–739.
   PubMed Web of Science ®Google Scholar
• Ali H, Mohamed MM, Sharma A, et al. Outcomes of interleukin-2 receptor antagonist induction therapy in standard-risk renal transplant recipients maintained on tacrolimus: a systematic review and meta-analysis. Am J Nephrol. 2021;52(4):279–291.
   PubMed Web of Science ®Google Scholar
• Professionaleducation.blood.ca [Internet]. 2022; [cited 13 April 2022]. Available from: https://professionaleducation.blood.ca/sites/default/files/Immunologic-Risk.pdf
   Google Scholar
• Webster AC, Playford EG, Higgins G, et al. Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials. Transplantation. 2004;77(2):166–176.
   PubMed Web of Science ®Google Scholar
• Lasmar MF, Dutra RS, Nogueira-Machado JA, et al. Effects of immunotherapy induction on outcome and graft survival of kidney-transplanted patients with different immunological risk of rejection. BMC Nephrol. 2019;20(1):314.
   PubMed Web of Science ®Google Scholar
• Baker R, Jardine A, Andrews P. Renal association clinical practice guideline on post-operative care of the kidney transplant recipient. Nephron Clin Pract. 2011;118 Suppl 1:c311–c347.
   PubMedGoogle Scholar
• Webster AC, Ruster LP, McGee R, et al. Interleukin 2 receptor antagonists for kidney transplant recipients. Cochrane Database Syst Rev. 2010;(1): Art. No.: CD003897. DOI: 10.1002/14651858.CD003897.pub3.
   Web of Science ®Google Scholar
• Levey AS, Eckardt KU, Dorman NM, et al. Nomenclature for kidney function and disease: executive summary and glossary from a kidney disease: improving global outcomes (KDIGO) consensus conference. Ren Fail. 2020;42(1):560–566.
   PubMed Web of Science ®Google Scholar
• Thymoglobulin Lead Page [Internet]. U.S. Food and Drug Administration; 2021 [cited April 28]. Available from: https://www.fda.gov/vaccines-blood-biologics/approved-blood-products/thymoglobulin
   Google Scholar
• Zsom L, Wagner L, Fülöp T. Minimization vs tailoring: where do we stand with personalized immunosuppression during renal transplantation in 2015? World J Transplant. 2015;5(3):73–80.
   PubMedGoogle Scholar
• Parner E, Andersen P. Regression analysis of censored data using pseudo-observations. Stata J. 2010;10(3):408–422.
   Web of Science ®Google Scholar
• Johansen MN, Lundbye-Christensen S, Larsen JM, et al. Regression models for interval censored data using parametric pseudo-observations. BMC Med Res Methodol. 2021;21(1):36.
   PubMed Web of Science ®Google Scholar
• Sureshkumar KK, Chopra B. Induction type and outcomes in HLA-DR mismatch kidney transplantation. Transplant Proc. 2019;51(6):1796–1800.
   PubMed Web of Science ®Google Scholar
• Opelz G, Döhler B. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation. 2007;84(2):137–143.
   PubMed Web of Science ®Google Scholar
• Williams RC, Opelz G, McGarvey CJ, et al. The risk of transplant failure with HLA mismatch in first adult kidney allografts from deceased donors. Transplantation. 2016;100(5):1094–1102.
   PubMed Web of Science ®Google Scholar
• Lim WH, Chadban SJ, Clayton P, et al. Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients. Clin Transplant. 2012;26(4):E428–E437.
   PubMed Web of Science ®Google Scholar
• Coupel S, Giral-Classe M, Karam G, et al. Ten-year survival of second kidney transplants: impact of immunologic factors and renal function at 12 months. Kidney Int. 2003;64(2):674–680.
   PubMed Web of Science ®Google Scholar
• Doxiadis IIN, de Fijter JW, Mallat MJK, et al. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility. Transplantation. 2007;83(9):1207–1213.
   PubMed Web of Science ®Google Scholar
• Opelz G. Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment. Transplantation. 1985;40(3):240–243.
   PubMed Web of Science ®Google Scholar
• Opelz G. Collaborative transplant study data on efficacy of cyclosporine A in renal transplantation. Transplant Proc. 1988;20(5 Suppl 6):41–44.
   Google Scholar
• Gilks WR, Bradley BA, Gore SM, et al. Substantial benefits of tissue matching in renal transplantation. Transplantation. 1987;43(5):669–674.
   PubMed Web of Science ®Google Scholar
• Ali H, Soliman K, Daoud A, et al. Relationship between rabbit anti-thymocyte globulin and development of PTLD and its aggressive form in renal transplant population. Ren Fail. 2020;42(1):489–494.
   PubMed Web of Science ®Google Scholar
• Senev A, Coemans M, Lerut E, et al. Eplet mismatch load and de novo occurrence of donor-specific anti-HLA antibodies, rejection, and graft failure after kidney transplantation: an observational cohort study. J Am Soc Nephrol. 2020;31(9):2193–2204.
   PubMed Web of Science ®Google Scholar
• Leeaphorn N, Pena JRA, Thamcharoen N, et al. HLA-DQ mismatching and kidney transplant outcomes. Clin J Am Soc Nephrol. 2018;13(5):763–771.
   PubMed Web of Science ®Google Scholar
• Lim WH, Chapman JR, Coates PT, et al. HLA-DQ mismatches and rejection in kidney transplant recipients. Clin J Am Soc Nephrol. 2016;11(5):875–883.
   PubMed Web of Science ®Google Scholar
• Heidt S, Roelen DL, de Vaal YJ, et al. A NOVel ELISPOT assay to quantify HLA-specific B cells in HLA-immunized Individuals. Am J Transplant. 2012;12(6):1469–1478.
   PubMed Web of Science ®Google Scholar